Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem D F Venter

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2011
Providing immediate CD4 count results at HIV testing improves ART initiationMamsallah Faal, Nicolette Naidoo, Deborah K Glencross, et al.
AIDS Research and Treatment|April 15, 2011
Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South AfricaCarole L Wallis, John W Mellors, Willem D F Venter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2009
Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South AfricaCarole L Wallis, John W Mellors, Willem D F Venter, et al.
AIDS Research and Human Retroviruses|July 22, 2009
A longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudineJaya A George, Willem D F Venter, Hendrick E Van Deventer, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 1, 2009
Symptomatic hyperlactataemia in adults on antiretroviral therapy: a single-centre experienceJune Fabian, Willem D F Venter, Louisa Mkhabela, et al.
Journal of the International AIDS Society|October 6, 2021
Retention in care and viral suppression after same-day ART initiation: One-year outcomes of the SLATE I and II individually randomized clinical trials in South AfricaMhairi Maskew, Alana T Brennan, Willem D F Venter, et al.
Journal of Clinical Microbiology|May 8, 2009
Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assaysLesley E Scott, Lara D Noble, Jackie Moloi, et al.
Ethnicity & Disease|June 2, 2009
Urinary screening abnormalities in antiretroviral-naive HIV-infected outpatients and implications for management--a single-center study in South AfricaJune Fabian, Saraladevi Naicker, Willem D F Venter, et al.
BMC Public Health|August 24, 2017
Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trialWillem D F Venter, Mohammed Majam, Godspower Akpomiemie, et al.
AIDS Research and Human Retroviruses|May 30, 2008
Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4Katherine Michler, Bridgette J Connell, Willem D F Venter, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2011
Providing immediate CD4 count results at HIV testing improves ART initiationMamsallah Faal, Nicolette Naidoo, Deborah K Glencross, et al.
AIDS Research and Treatment|April 15, 2011
Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South AfricaCarole L Wallis, John W Mellors, Willem D F Venter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2009
Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South AfricaCarole L Wallis, John W Mellors, Willem D F Venter, et al.
AIDS Research and Human Retroviruses|July 22, 2009
A longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudineJaya A George, Willem D F Venter, Hendrick E Van Deventer, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 1, 2009
Symptomatic hyperlactataemia in adults on antiretroviral therapy: a single-centre experienceJune Fabian, Willem D F Venter, Louisa Mkhabela, et al.
Journal of the International AIDS Society|October 6, 2021
Retention in care and viral suppression after same-day ART initiation: One-year outcomes of the SLATE I and II individually randomized clinical trials in South AfricaMhairi Maskew, Alana T Brennan, Willem D F Venter, et al.
Journal of Clinical Microbiology|May 8, 2009
Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assaysLesley E Scott, Lara D Noble, Jackie Moloi, et al.
Ethnicity & Disease|June 2, 2009
Urinary screening abnormalities in antiretroviral-naive HIV-infected outpatients and implications for management--a single-center study in South AfricaJune Fabian, Saraladevi Naicker, Willem D F Venter, et al.
BMC Public Health|August 24, 2017
Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trialWillem D F Venter, Mohammed Majam, Godspower Akpomiemie, et al.
AIDS Research and Human Retroviruses|May 30, 2008
Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4Katherine Michler, Bridgette J Connell, Willem D F Venter, et al.
Pageof 7